Goldan Keith A. bought SNDX
February 4, 2026 · Form 4 insider transaction
Goldan Keith A. bought 118,000 shares of Syndax Pharmaceuticals, Inc. at $20.43 per share, a transaction worth $2.41M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
118,000
Price
$20.43
Total value
$2.41M
InsiderGoldan Keith A.
RoleOfficer
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 6, 2026
Shares owned after118,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to the option shall vest monthly over a four-year period.